Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
05/2004
05/20/2004US20040097483 Benzimidazole derivatives useful as histamine H3 antagonists
05/20/2004US20040097471 For therapy and prophylaxis of influenza infection
05/20/2004US20040097438 Fused-ring compounds and use thereof as drugs
05/20/2004US20040097376 Controlling weeds
05/19/2004EP1420015A1 Imidazolyl derivatives
05/19/2004EP1419771A1 Preventive and/or remedial agent for disease attributable to arteriosclerotic activity
05/19/2004EP1419770A1 Apo ai expression accelerating agent
05/19/2004EP1419152A1 Hiv inhibiting pyrimidines derivatives
05/19/2004EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
05/19/2004EP1418916A1 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
05/19/2004EP1418911A1 2,4,5-trisubstituted thiazolyl derivatives ant their antiinflammatory activity
05/19/2004EP1418909A2 2-amino-4, 5-trisubstituted thiaolyl derivatives and their use against autoimmune diseases
05/19/2004EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
05/19/2004EP1131308B1 New piperazine and piperidine compounds
05/19/2004EP1086097B1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
05/19/2004EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
05/19/2004EP0941227B1 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent
05/19/2004EP0874629B1 ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS
05/19/2004CN1496981A Cycloamine derivative and its use as medicine
05/19/2004CN1150191C Aminoalkyl substituted benzodioxan derivatives
05/19/2004CN1150190C 4-(caminomethyl)-piperidine benzamides for treating gastrointestinal disorders
05/19/2004CN1150185C Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositiions contg. said compounds and use thereof
05/19/2004CN1150178C Sidechain-bearing taxanes
05/19/2004CN1150165C 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivativer for treatment of CNS disorders
05/18/2004US6737429 Pyrrole derivatives
05/18/2004US6737422 Voltage-dependent
05/13/2004WO2004039811A2 A method for manufacture of ceftiofur
05/13/2004WO2004039800A1 Cyclic sulfamides for inhibition of gamma-secretase
05/13/2004WO2004039799A1 Cyclopropyl-thienyl-carboxamide as fungicides
05/13/2004WO2004039795A2 Amide compounds for the treatment of hyperlipidemia
05/13/2004WO2004039370A1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors
05/13/2004WO2004039365A1 Agent for preventing or treating neuropathy
05/13/2004WO2004029066A8 Bifunctional heterocyclic compounds and methods of making and using same
05/13/2004WO2004026305A9 Diaryl ethers as opioid receptor antagonist
05/13/2004WO2004024065A3 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use
05/13/2004WO2004014885B1 Amino benzothiazole compounds with nos inhibitory activity
05/13/2004WO2002055013A8 Therapeutic chromone compounds
05/13/2004US20040093165 Estrogen receptor ligands
05/13/2004US20040092746 Fungicides
05/13/2004US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists
05/13/2004US20040092740 Hyperpermeability; diabetic retinopathy, ischemic retinal-vein occlusion, prematurity, age-related macular degeneration
05/13/2004US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders
05/13/2004US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
05/13/2004US20040092562 Methods for treating inflammatory conditions or inhibiting JNK
05/13/2004US20040092561 Azolidinone-vinyl fused -benzene derivatives
05/13/2004US20040092560 Degradation of epothilones
05/13/2004US20040092556 Aids therapy
05/13/2004US20040092555 Pharmaceutical compositions of a thiazolidinedione derivative and their use as antidiabetics
05/13/2004US20040092538 Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
05/13/2004US20040092526 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
05/13/2004US20040092524 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same
05/13/2004US20040092521 Antihistamines; central nervous system disorders
05/13/2004US20040092507 Melanocortin receptor agonists
05/13/2004US20040092503 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
05/13/2004US20040092501 Acylated piperidine derivatives as melanocortin-4 receptor agonists
05/13/2004US20040092497 Heteroarylakanoic acids as intergrin receptor antagonists
05/13/2004US20040092478 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
05/13/2004US20040091523 Pharmaceutical composition and the process for its preparation
05/13/2004CA2504511A1 Agent for preventing or treating neuropathy
05/13/2004CA2503885A1 A method for manufacture of ceftiofur
05/12/2004EP1418176A1 Pyrazole derivates, their preparation and their use in drugs
05/12/2004EP1418175A1 Respiratory syncytial virus replication inhibitors
05/12/2004EP1418174A2 Amorphous Ritonavir
05/12/2004EP1417202A2 Aminopiperidine derivatives as modulators of chemokine receptor activity
05/12/2004EP1417196A1 Dna-pk inhibitors
05/12/2004EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor
05/12/2004EP1417189A1 Acylaminothiazole derivatives, their preparation and therapeutic use
05/12/2004EP1417188A1 Novel 2,4-diaminothiazole derivatives
05/12/2004EP1417187A1 Aryl substituted thiazolidinones and the use thereof
05/12/2004EP1417176A1 Substituted anthranilamides for controlling invertebrate pests
05/12/2004EP1417173A1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands
05/12/2004EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor
05/12/2004EP1416931A1 Inhibitors of polyq-aggregation
05/12/2004EP1416928A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
05/12/2004EP1250336B1 Piperidine derivatives and their use as serotonin receptor antagonists
05/12/2004EP1140835B1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
05/12/2004EP1066267B1 Substituted phenyl uracils
05/12/2004EP1063235B1 Benzofurylpyrone derivatives
05/12/2004EP1062212B1 Heterocyclyl anthracyclinone derivatives
05/12/2004EP1015429B1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
05/12/2004EP0960105B1 Benzofurazan compounds that enhance ampa receptor activity
05/12/2004EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production
05/12/2004CN1496365A Herbicidal heterocyclic compound
05/12/2004CN1496364A Substituted quinazoline derivatives and their use as inhibitors
05/12/2004CN1496362A Non-imidazole compounds as histamine H3 antagonists
05/12/2004CN1496259A New use
05/12/2004CN1496256A Combination of EPOTHILONE analogs and chemotherapeutic agents for treatment of proliferative diseases
05/12/2004CN1495180A Method for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative
05/12/2004CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application
05/12/2004CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy
05/12/2004CN1149211C Benzoyl derivatives, method for producing them and their use as herbicids and plant growth regulators
05/12/2004CN1149210C Thrombin inhibitors
05/12/2004CN1149209C Triazole compounds with dopamine-D3-receptor affinity
05/12/2004CN1149205C Polycyclic thiazole systems and their utilization as anorectics
05/12/2004CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
05/12/2004CN1149191C Azetidine derivatives, Preparation and medicines containing them
05/12/2004CN1149085C Inhibition of RAF kinase using substituted heterocyclic useas
05/11/2004US6734200 Antibiotic compounds containing a substituted oxazolidinone ring; activity against gram-positive pathogens
05/11/2004US6734191 Chemokine receptor binding heterocyclic compounds
05/11/2004US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)